Protein kinase C (PKC) is implicated in the potentiation of Ca v 2.3 currents by acetyl-β-methylcholine (MCh), a muscarinic M 1 receptor agonist or phorbol-12-myristate, 13-acetate (PMA). The PKC isozymes responsible for the action of MCh and PMA were investigated using translocation as a measure of activation and with isozyme-selective antagonists and siRNA. Ca v channels were expressed with α 1 2.3, β 1 b and α 2 δ subunits and muscarinic M 1 receptors in the Xenopus oocytes and the expressed currents (I Ba ) were studied using Ba 2+ as the charge carrier. Translocation of PKC isozymes to the membrane studied by Western blot revealed that all eleven known PKC isozymes are present in the Xenopus oocytes. Exposure of the oocytes to MCh led to the translocation of PKC α whereas PMA activated PKC βII and ε isozymes. The action of MCh was inhibited by Go 6976, an inhibitor of cPKC isozymes or PKC α siRNA. PMA-induced potentiation of Ca v 2.3 currents was inhibited by CG533 53, a PKC βII antagonist, βIIV5.3, a peptide translocation inhibitor of PKC βII or PKC βII siRNA. Similarly, εV1.2, a peptide translocation inhibitor of PKC ε or PKC ε siRNA inhibited PMA action. The inhibitors of PKC increased the basal I Ba slightly. It is possible that some PKC isozymes have negative control over the I Ba . Our results implicate PKC α in the potentiation of Ca v 2.3 currents by MCh and PKC βII and ε in the potentiation of Ca v 2.3 currents by PMA.
Classification of termsSection: 3. Neurophysiology, Neruopharmacology and other forms of Interceullular communication